Skip to main content
search
Toggle navigation
Main navigation
Our Scientists
Biomedical Research
Overview
Programs
Centers
Translational Research
Shared Resources
Partnering
Education
Overview
Postdoctoral Training
Graduate School
International Services
NIH T32 Fellowships
Contact
News & Calendar
News
Calendar
Magazine
Media Resources
Discoveries Newsletter
Insights
COVID-19
Support Us
Overview
Donate Now
President's Circle
Catalyst Club
Support a Project
Tributes
Contact
About
Overview
Leadership
Trustees
History
Careers
Contact
Content type
Article
Blog
Event
Basic page
Paper of the Week
Person
Pathways Magazine
Press
Promo
Shared Resource
All categories
News
All other content
Relevance
Date
Search
close
News
Main navigation - LV 2
News
News
Calendar
Magazine
Media Resources
Discoveries Newsletter
Insights
COVID-19
News
All
Press Releases
In The News
Blog
Paper of the Week
Blog
Mark your calendars: Padres Pedal the Cause is back
January 20, 2022
After a brief slowdown, Padres Pedal the Cause is ready to ride again.
Blog
New COVID-19 drug passes phase 2 clinical trial
January 18, 2022
The new treatment, developed by Avalo Therapeutics with Sanford Burnham Prebys researchers, can mitigate lung damage and improve survival in COVID patients.
Press Release
Sanford Burnham Prebys researchers awarded $3.6 million to study antibiotic resistance
January 13, 2022
The five-year project will utilize an “evolution machine” to shed new light on how bacteria develop antibiotic resistance.
Paper of the Week
Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells
January 11, 2022
Paper of the Week
Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P1-selective modulation
January 5, 2022
Pagination
1
2
3
4
5
…
›
›
»
Last
Sanford Burnham Prebys Newsletter
Subscribe to our monthly email newsletter
Discoveries
.
